Arca
Skip to content

Celiac disease

Drug research and approvals for celiac disease: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 16, 2026, 59 studies of celiac disease are recruiting on ClinicalTrials.gov, and Health Canada has authorized 8 drug trials for it since 2013.

  • Recruiting worldwide: 59
  • Trials authorized in Canada: 8
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting Now

Newest start dates first, of 59 recruiting on ClinicalTrials.gov ↗

Trials Authorized in Canada

Newest first; search them all in Canada trials
Jun 27, 2024A phase 2a/b, randomized, double-blind, placebo-controlled, parallel-group study to investigate the efficacy and safety of subcutaneous amlitelimab in adult…AMLITELIMAB (SAR445229) / VITEN / PROSOLVSANOFI-AVENTIS CANADA INCOngoing
Dec 7, 2023Phase 2a double-blind, placebo-controlled study to evaluate the efficacy, safety, and tolerability of kan-101 in participants with celiac diseaseKAN-101KANYOS BIO INC. (A WHOLLY OWNED SUBSIDIARY OF ANOKION S.A.)Closed
Oct 18, 2022A randomized, double-blind, placebo-controlled, phase 2 dose-ranging study to evaluate the efficacy and safety of tak-101 for the prevention of gluten-specific…TAK-101Takeda Pharmaceuticals USAOngoing
Aug 4, 2022Restoration of impaired microbiota-mediated aryl hydrocarbon receptor signaling in celiac disease by oral tryptophan supplementation: an exploratory studyTRYPTOPHANMCMASTER UNIVERSITY MEDICAL CENTREOngoing
Jul 29, 2022A phase 2, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of tak-062 for the treatment of active celiac…TAK-062Takeda Pharmaceuticals USAOngoing
Oct 2, 2020A phase 2b, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of prv-015 in adult patients with…PRV-015 (AMG 714)SanofiOngoing
Oct 22, 2019A phase 3, randomized, double-blind, placebo controlled study to evaluate the efficacy and safety of larazotide for relief of persistent symptoms in patients…LARAZOTIDE9 METERS BIOPHARMA, INC.Closed
Dec 27, 2013A phase 2b, randomized, double-blind, placebo-controlled, dose-ranging study of alv003 treatment in symptomatic celiac disease patients maintained on a…ALV003ALVINE PHARMACEUTICALS INCOngoing

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.